Regenxbio is a company that provides the delivery mechanism for gene therapies to penetrate the blood/brain barrier. I became interested due to having a family member (child) with a genetic disease. We have for years been working with non-profit organizations working on elusive treatments and/or cures and the biggest obstacle mentioned was always being able to penetrate the blood/brain barrier. I am a novice for both investing and biotech company knowledge so was wondering if any of you are familiar with this company and could share any of your insights.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.